This content is machine translated Mild to moderate psoriasis vulgaris Swiss treatment pathway for topical psoriasis therapy 2021 Topical treatment of plaque psoriasis has a high priority in the everyday clinical practice. In mild symptoms, topical topical preparations are the mainstay of therapy; in moderate to severe cases, they…
View Post 2 min This content is machine translated Plaque psoriasis Secukinumab ready-to-use 300 mg injection convinces The EMA-approved new route of administration for the IL-17A inhibitor allows the recommended dosage to be administered in a single injection. Data analyses of the pivotal phase IIIb MATURE study…
View Post 3 min This content is machine translated Seborrheic dermatitis Miconazole nitrate and ketaconazole as equivalent topical therapy options. The episodic scaling dermatosis leads to a high degree of suffering. Dermatological shampoos containing antifungal substances have been shown to alleviate symptoms in the capillitium area. In a multicenter study,…
View Post 4 min This content is machine translated Moderate to severe atopic dermatitis Modern system therapies “revisited” – advantages and disadvantages in clinical practice In an interview with DERMATOLOGIE PRAXIS, PD Dr. Dr. med. Ahmad Jalili, specialist in dermatology and venereology at the Dermatology & Skin Care Clinic and president of DermaNet Switzerland, talks…
View Post 5 min This content is machine translated Neurodermatitis in children and adolescents Consistent topical basic care – the foundation of every successful therapy Pathophysiologically, a disturbed skin barrier with a lack of natural moisturizing factors and altered lipid and protein composition plays a key role in atopic dermatitis. Restoring physiological skin barrier function…
View Post 11 min This content is machine translated Atopic dermatitis The role of the key cytokine IL-13 The Th2 response of atopic dermatitis is strongly controlled by IL-13, which activates the type II receptor by binding to the IL-13Rα chain. IL-13 is expressed at higher levels than… CME-Test
View Post 4 min This content is machine translated Chronic spontaneous urticaria FcεRI as a potential biomarker for treatment response to omalizumab. In patients with chronic spontaneous urticaria, high baseline serum FcεRI levels may be a predictor of response to omalizumab treatment. This is the conclusion of a study presented at the…
View Post 5 min This content is machine translated Pollen allergy Specific subcutaneous immunotherapy – What’s new? Specific immunotherapy (SIT) is the only disease-modifying and curative form of therapy for the treatment of immediate-type allergies. In contrast to symptomatic pharmacological therapies, SIT pursues the goal of sustained…
View Post 4 min This content is machine translated Moderate to severe atopic dermatitis JAK inhibitor upadacitinib a clear winner in comparative study with dupilumab The development of innovative drugs for the treatment of atopic dermatitis (AD) is increasingly focused on targeted therapies that selectively interfere with disease-causing signaling pathways [1]. That the Janus kinase…
View Post 6 min This content is machine translated Chronic spontaneous urticaria (csU) Effectively treating wheals and angioedema – a practice-based update. The therapeutic goal of complete freedom from symptoms is realistic in many cases thanks to the treatment options available today. H1 antihistamines are still considered first-line therapy, and the use…
View Post 5 min This content is machine translated Psoriasis, Atopic Dermatitis, Urticaria “The big three” in dermatology In psoriasis as well as in atopic dermatitis and urticaria, the primary goal of treatment is to achieve symptom control and symptom relief, respectively. The therapy is stage-adapted. Because these…
